Anzatax is used to treat metastatic ovarian cancer when conventional therapies with anthracycline and platinum have failed or are contraindicated.

Ovarian cancer is a malignant tumor that originates from one or both ovaries. According to statistics, the incidence of ovarian cancer is about 4.6/100,000 women. The disease can occur at many ages, but is most common in women over 50.

Ovarian cancer is one of the most common reproductive tract cancers in women, second only to cervical cancer. Currently, chemotherapy is considered the first-line treatment for cancers in general and ovarian cancer in particular.

Ovarian cancer is the second most common cancer of the reproductive organs in women. It usually occurs in women between the ages of 50 and 65. A woman's risk of ovarian cancer is about 1.4%.

Ovarian cancer occurs when normal cells in the ovary change into abnormal cells and grow out of control. Ovarian organs are part of the female reproductive system. A woman's eggs are located in the ovaries. Ovarian cancer most commonly occurs in women between the ages of 50 and 65, but can still occur in younger or older women. Sometimes ovarian cancer runs in families.

Ovarian cancer is one of the most common gynecological cancers in women, second only to cervical cancer. There are many factors that affect the risk of ovarian cancer. Understanding these factors can help prevent and detect the disease at an early stage and make treatment more effective.

Early-stage ovarian cancer often has atypical manifestations, even very difficult to recognize, but has the highest probability of being successfully treated. Recognizing early signs of breast cancer helps in timely treatment to increase the likelihood of recovery.

Ovarian cancer is one of the most common genital cancers in women, second only to cervical cancer. This disease is known as the "silent killer" because of its silent, silent progression, indistinct symptoms and often overlooked by women. So what are the treatments for ovarian cancer?

Ovarian cancer is a dangerous disease with a high mortality rate in the gynecological cancer group because the symptoms are not clear, so the patients are often not actively examined and detected early.

Ovarian cancer is a dangerous gynecological disease with a high mortality rate because of its silent progression, difficult to detect early. Routine ovarian cancer screening is considered an effective solution in early detection and treatment of this disease.

Ovarian cancer is a "death sentence" for women, because the disease progresses quietly, when detected, it is often in the late stages and cannot be treated. Cancer screening is the best option for early detection. So how to screen for ovarian cancer? Please refer to the following article!